QIZILO’NGACH SARATONI KELIB CHIQISHI VA KIMYOTERAPIYAVIY DAVO USULLARI
Keywords:
qizilo‘ngach saratoni, anatomiya, disfagiya, metastaz, limfa tugunlari, endoskopiya.Abstract
Ushbu maqolada qizilo‘ngach saratonining anatomik tuzilishi, rivojlanish mexanizmlari va klinik ahamiyati yoritilgan. Qizilo‘ngach devorining qavatlari, qon va limfa ta’minoti hamda o‘smaning tarqalish yo‘llari tahlil qilinadi. Shuningdek, kasallikning asosiy gistologik turlari — Squamous cell carcinoma va Esophageal adenocarcinoma haqida ma’lumot beriladi. Erta tashxis qo‘yish va anatomik bilimlarning davolash samaradorligidagi o‘rni ko‘rsatib berilgan.
References
1.Al-Batran SE, Homann N, Pauligk C, Goetze TO, Meiler J, Kasper S, Kopp HG, Mayer F, Haag GM, Luley K, Lindig U, Shmiegel V, Pohl M, Stoehlmacher J, Folprecht G, Probst S, Prasnikar N, Fischbachberg M, Martmans, UM, Thiss-Patience P, Egger M, Blok A, Heinemann V, Illerhaus G, Moehler M, Schenk M, Kullmann F, Behringer DM, Heike M, Pink D, Teschendorf C, Löhr C, Bernhard H, Schuch G, Rethwisch V, von LF Weikers, Xartnthalman Schulmann K, Weniger J, Belle S, Gaiser T, Oduncu FS, Guntner M, Hozaeel W, Reichart A, Jäger E, Kraus T, Mönig S, Bechstein WO, Schuler M, Schmalenberg H, Hofheinz RD., FLOT4-AIO tadqiqotchilari. Mahalliy rivojlangan, rezektsiya qilinadigan oshqozon yoki gastro-qizilo'ngach adenokarsinomasi (FLOT4) uchun ftorurasil va leykovorin, oksaliplatin va dotsetaksel bilan perioperativ kimyoterapiya, ftorurasil yoki kapetsitabin va sisplatin va epirubitsin bilan solishtirganda: randomizatsiyalangan, 2/3-bosqich sinovi. Lancet. 2019-yil 11-may; 393 (10184):1948-1957. [ PubMed ]
2.Doki Y, Ajani JA, Kato K, Xu J, Wyrwicz L, Motoyama S, Ogata T, Kavakami X, Xsu CH, Adenis A, El Xajbi F, Di Bartolomeo M, Braghiroli MI, Holtved E, Ostoich SA, Kim T HR, Ueno M, Yang Vrijyu, Mansoor V, Xynos I, Liu X, Lei M, Kondo K, Patel A, Gricar J, Chau I, Kitagawa Y., CheckMate 648 sinov tergovchilari. Qizilo'ngachning skuamoz hujayrali karsinomasida Nivolumab kombinatsiyalangan terapiyasi. N Engl J Med. 2022 yil 03 fevral; 386 (5): 449-462. [ PubMed ]
3.Sun JM, Shen L, Shah MA, Enzinger P, Adenis A, Doi T, Kojima T, Metges JP, Li Z, Kim SB, Cho BC, Mansoor W, Li SH, Sunpaweravong P, Maqueda MA, Goekkurt E, Hara H, Antunes L, Fountzilas C, Tsuji A, Oliden VC, Liu Q, Shah S, Bhagia P, Kato K., KEYNOTE-590 Tadqiqotchilari. Qizilo'ngachning rivojlangan saratonini birinchi darajali davolash uchun pembrolizumab va kimyoterapiya (KEYNOTE-590): randomizatsiyalangan, platsebo nazoratidagi, 3-bosqich tadqiqoti. Lancet. 2021-yil 28-avgust; 398 (10302):759-771. [ PubMed ]
4.Siegel RL, Miller KD, Fuchs HE, Jemal A. Saraton statistikasi, 2022. CA Cancer J Clin. 2022 Yanvar; 72 (1):7-33. [ PubMed ]
5. Siegel RL, Miller KD, Fuchs HE, Jemal A. Saraton statistikasi, 2021. CA Cancer J Clin. 2021 Yanvar; 71 (1):7-33. [ PubMed ]
